LIFETIME HEART & VASCULAR USES INNOVATIVE TREATMENT IN GILBERT FOR PATIENTS WITH CHRONIC VENOUS INSUFFICIENCY (CVI)
Lifetime Heart & Vascular is now using innovative technology for the treatment of chronic venous insufficiency (CVI), a disease that impacts 190 million people globally3 (more than 30 million Americans). Chronic venous insufficiency involves dysfunction of the valve within the vein, which helps control proper blood from.
“As a progressive disease, it is important for patients to evaluate treatment options that demonstrate long-term effectiveness of the procedure given the chance of reoccurrence,” said Gautam Kedia, MD. “Data published in the British Journal of Surgery found that CVI patients treated with the ClosureFast™ procedure had strong closure rates and minimal treatment side effects at five years.”
With CVI and varicose veins, the valves in the leg veins that direct blood from the legs back toward the heart no longer function properly, causing blood to pool in the legs. Although this can occur at any time, increased age is a risk factor. Varicose veins and CVI also tend to be more prevalent in women who have been pregnant, in people who have a family history of CVI or those whose jobs require them to spend a great deal of time standing.